INTRODUCTION
Neurodevelopmental disorders (NDDs), including specific epilepsy subtypes, schizophrenia, intellectual disability, and autism spectrum disorders (ASDs), exhibit a shared spectrum of pathological changes in neuronal morphology, synapse function, and network properties (Deidda et al., 2014; Pasciuto et al., 2015; Cattane et al., 2018) . A fundamental obstacle to developing novel therapies for NDDs is our limited knowledge of disease pathogenesis.
Recent data has implicated impaired function of the neuronal potassium/chloride extruder KCC2 in the pathogenesis of multiple NDDs (Schulte et al., 2018) . (Kahle et al., 2016b) , schizophrenia (Hyde et al., 2011; Sullivan et al., 2015) , and Rett syndrome (Duarte et al., 2013) , as well as in mouse models of Fragile X (Tyzio et al., 2014) and Rett syndrome diseases (El-Khoury et al., 2014; Banerjee et al., 2016) . However, due to the post-translational regulation of KCC2, there is no simple relationship between the abundance of KCC2 protein and its activity as chloride extruder (Kahle et al., 2013) . Phosphorylation of KCC2 at specific residues strongly affects the ion transport activity of the transporter (Lee et al., 2007 (Lee et al., , 2010 Inoue et al., 2012; Weber et al., 2014; Friedel et al., 2015; Cordshagen et al., 2018) .
Among multiple KCC2 phosphorylation sites (Payne et al., 1996; Lee et al., 2007 Lee et al., , 2010 Weber et al., 2014; Agez et al., 2017; Cordshagen et al., 2018) , the dual (de)phosphorylation of threonine 906 and 1007 (Thr 906 /Thr 1007 ) is a particularly potent regulator of KCC2 activity (Lee et al., 2007 (Lee et al., , 2011 Rinehart et al., 2009; Inoue et al., 2012; Friedel et al., 2015; Moore et al., 2018) . Thr 906 /Thr 1007 becomes progressively dephosphorylated during neuronal development (Rinehart et al., 2009; Friedel et al., 2015) . The phospho-mimetic threonine [T] to glutamate [E] (T906E/T1007E) mutations of KCC2 result in strong inhibition of the iontransport activity in different cell lines and cultured neurons (Rinehart et al., 2009; Inoue et al., 2012; Friedel et al., 2013) . Unlike wild type KCC2 construct, who's in vitro overexpression in immature neurons reduces [Cl - ] i and produces hyperpolarizing shift of GABA receptor type A (GABA A R) responses, the overexpression of T906E/T1007E mutant results in an increase in [Cl - ] i , and a depolarizing shift of GABA A R responses (Inoue et al., 2012; Friedel et al., 2015) .
The importance of precise post-translational KCC2 regulation has been corroborated by the identification of mutations that impair these processes in human patients with NDDs, including epilepsy (Kahle et al., 2014; Merner et al., 2015; Stödberg et al., 2015) . However, the pathophysiological consequences and mechanisms of impaired K-Cl co-transporters phosphorylation has only begun to be explored in vivo (Silayeva et al., 2015 , Kahle et al., 2016a Moore et al., 2018) .
Here, we have generated a KCC2 transgenic mouse carrying the phospho-mimetic threonine to glutamate [E] mutations at KCC2 Thr 906 and Thr 1007 , which mimics constitutive phosphorylation and prevents normal developmental dephosphorylation at these sites (Rinehart et al., 2009; Inoue et al., 2012; Friedel et al., 2015) . KCC2 E/E homozygous mice die at birth, highlighting that precise phospho-regulation of these sites is essential for post-natal survival. In contrast, heterozygous (KCC2 
METERIALS AND METHODS

Animals
The study was performed on KCC2 E/+ and KCC2 +/+ mixed background SV129/C57bl6-J mice. Animals were housed in a temperature-controlled environment with a 12-h light/dark cycle and free access to water and food. All procedures were in accordance with the European Communities Council Directive (86/609/EEC).
Production of Kcc2 double point mutant targeted ES cell clones
Linearized targeting vector was transfected into 129Sv ES cells (genOway, Lyon, France) according to genOway's electroporation procedures. PCR, Southern blot and sequence analysis of G-418 resistant ES clones revealed 2 clones as carrying the recombined locus.
PCR over the 5' end of the targeted locus was performed with a forward primer hybridizing upstream of the 5' homology arm (5'-ATAGCGTTGGCTACCCGTGATATTGC-3') and a reverse primer hybridizing within the Neomycin cassette (5' AGGCTAGGCACAGGCTACATCCACAC-3'). Two Southern blot assays, assessing the correct recombination event at the 5' end and at the 3' end of the Kcc2 locus, were performed.
These assays are based on the use of an internal and of an external probe, respectively.
Finally, the integrity of the point mutations was confirmed by sequence analysis.
Generation of chimeric mice and breeding scheme
Recombined ES cell clones were microinjected into C57BL/6 blastocysts, and gave rise to male chimeras with a significant ES cell contribution. These chimeras were bred with C57BL/6J mice expressing Cre-recombinase, to produce the Kcc2 double point mutant heterozygous line devoid of the Neomycin cassette. For each line, F1 genotyping was performed by PCR and Southern blot. PCR primers hybridizing upstream (5'-GTGGTTCGCCTATGGGATCTGCTACTC-3') and downstream (5'-AGACAAGGGTTCATGTAACAGACTCGCC-3') of the Neomycin cassette allowed identification of the Kcc2 endogenous, double point mutant allele harboring the Neomycin cassette, and double point mutant devoid of the Neomycin cassette (298-bp, 1946-bp and 387-bp, respectively) . The Southern blot hybridized with an external probe allowed identification of the wild-type allele (14.1-kb) and the double point mutant allele (4.6-kb).
Genotyping
DNA extraction was performed with KAPA Mouse Genotyping Kit. 88µl of water, 10µl of KAPA express extract buffer and 2µl of KAPA express extract enzyme was mixed and placed on the Eppendorf containing a small piece of biopsy. Lysis was performed on thermocycler during 10 min at 75°C for lysis and 5 min at 95°C for enzyme inactivation. The mix reaction for PCR was composed of 14.5µl H2O, 5µl 5X buffer promega, 1.5µl MgCl2 (25mM) promega, 1.25µl primers, 0.25µl dNTP (25mM), 0.25µl GoTaq polymerase promega pink for 1µl of DNA. The primers were following: 93598cof-KKA1; AGA CAA GGG TTC ATG TAA CAG ACT CGC C and 93599cof-KKA1; GTG GTT CGC CTA TGG GAT CTG CTA CTC.
Hippocampal slice preparation and electrophysiological recordings
Brains were removed and immersed into ice-cold (2-4°C) artificial cerebrospinal fluid (ACSF) with the following composition (in mM): 126 NaCl, 3.5 KCl, 2 CaCl 2 , 1.3 MgCl 2 , 1.2 NaH 2 PO 4 , 25 NaHCO 3 and 11 glucose, pH 7.4 equilibrated with 95% O 2 and 5% CO 2 .
Hippocampal slices (400 µm thick) were cut with a vibrating microtome (Leica VT 1000s, Germany) in ice cold oxygenated choline-replaced ACSF and were allowed to recover at least 90 min in ACSF at room (25°C) temperature. Slices were then transferred to a submerged recording chamber perfused with oxygenated (95% O 2 and 5% CO 2 ) ACSF (3 ml/min) at 34°C. 10, glucose 10, Hepes-NaOH 10 (Tyzio et al., 2003 (Tyzio et al., , 2014 ; (2) for recordings of single NMDA channels: nominally Mg 2+ free ACSF with NMDA (10 µM) and glycine (1 µM) (Tyzio et al., 2003) . were excluded from analysis. Analysis of currents trough single channels and I-V curves were performed using Clampfit 9.2 (Axon Instruments) as described by (Tyzio et al., 2003) . 
Antibodies for Western blot
The following antibodies were raised in sheep and affinity-purified on the appropriate antigen by the Division of Signal Transduction Therapy Unit at the University of Dundee: KCC2A 
Immunoprecipitation with phosphorylation site-specific antibodies
KCCs phosphorylated at the KCC2 Thr 906 and Thr 1007 equivalent residue were immunoprecipitated from clarified hippocampal and cortical culture lysates (centrifuged at 16,000 x g at 4°C for 20 minutes) using phosphorylation site-specific antibody coupled to protein G-Sepharose as described (Los Heros et al., 2014) . The phosphorylation site-specific antibody was coupled with protein-G-Sepharose at a ratio of 1 mg of antibody per 1 mL of beads in the presence of 20 µg/mL of lysate to which the corresponding non-phosphorylated peptide had been added. 2 mg of clarified cell lysate were incubated with 15 µg of antibody conjugated to 15 µL of protein-G-Sepharosefor 2 hours at 4°C with gentle agitation. Beads were washed three times with 1 mL of lysis buffer containing 0.15 M NaCl and twice with 1 mL of buffer A. Bound proteins were eluted with 1X LDS sample buffer.
Immunoblotting
Hippocampi tissue lysates (15 µg) in SDS sample buffer were subjected to electrophoresis on polyacrylamide gels and transferred to nitrocellulose membranes. The membranes were incubated for 30 min with TTBS containing 5% (w/v) skim milk. The membranes were then immunoblotted in 5% (w/v) skim milk in TTBS with the indicated primary antibodies overnight at 4°C. Antibodies prepared in sheep were used at a concentration of 1-2 µg/ml.
The incubation with phosphorylation site-specific sheep antibodies was performed with the addition of 10 µg/mL of the nonphosphorylated peptide antigen used to raise the antibody.
The blots were then washed six times with TTBS and incubated for 1 hour at room temperature with secondary HRP-conjugated antibodies diluted 5000-fold in 5% (w/v) skim milk in TTBS. After repeating the washing steps, the signal was detected with the enhanced chemiluminescence reagent. Immunoblots were developed using a film automatic processor (SRX-101; Konica Minolta Medical) and films were scanned with a 600-dpi resolution on a scanner (PowerLook 1000; UMAX). Figures were generated using Photoshop and Illustrator (Adobe). The relative intensities of immunoblot bands were determined by densitometry with ImageJ software.
Behavior
All behavioral procedures were carried between 8:00 and 17:00 h under dim light conditions.
Male animals were moved to the testing room in their home cages 30 min prior to test beginning. The same animals have been used for all adulthood behavioral tests, starting at 6-week old. All experiments and analysis were done in blind genotyping by only one experimenter.
Vocalization: To induce vocalization, pups were isolated individually from their mother at P2-4-8-10-12. They were placed into an isolation box (23x28x18 cm) located inside a sound attenuating isolation cubicle (54x57x41 cm; Coulbourn Instruments, Allentown, PA, USA).
An ultrasound microphone sensitive to frequencies of 10 to 250 kHz (Avisoft UltraSoundGate
Condenser microphone capsule CM16/CMPA, Avisoft Bioacoustics, Berlin, Germany) was placed in the roof of the box. Vocalizations were recorded for 3 minutes using the Avisoft
Recorder software (version 4.2) with a sampling rate of 250 kHz in 16 bit format. Recordings were transferred to SASLab Pro (version 5.2; AvisoftBioacoustics) and a fast Fourier transformation was conducted (512 FFT-length, 100% frame, Hamming window and 75%time window overlap, cut off frequencies high pass 20Khz) before analyzing the number of calls emitted by mice.
Open field: The mice were individually placed in the square field (38.5 x 38.5cm; Noldus, Netherlands). Recording began 10 seconds after the mouse was placed inside the apparatus for a 10 minutes trial. Behaviors were recorded by a video camera fixed above the apparatus and analyzed using the Ethovision 11.5 software (Noldus, Netherlands). After each trial, the open field was cleaned with a solution containing 70% of ethanol. Anxiety and locomotor-like behaviors were analyzed using three parameters: the time spent in the center (12.8cm X 12.8cm), the number of entries in the center and the distance travelled.
Social interaction:
The 3-chamber test was performed as previously described (Peça et al., 2011) . The test was conducted in an apparatus (59 x 39.5cm; Noldus, Netherlands) divided in a central empty compartment (19.5 x 39.5 cm) and two side-compartments (19.5 x 39.5 cm)
containing a plastic cup-like cage for the strangers. The strangers were of the same sex and age as the tested mice and were habituated during 15min (one habituation per day) to the plastic cup-like cage 4 days prior to the beginning of the test. The mouse was recorded during 4 consecutive trials of 5 min. Trial 1, habituation: the tested mouse was placed in the empty compartment with the access to the other compartments closed. Trial 2, sociability testing: a first stranger was placed in a plastic cup-like cage in one of the two-side compartments and the tested mouse could explore freely all the compartments. Trial 3, post-test: the tested mouse could explore freely its environment and be habituated for a longer time to the stranger 1 (familiar stranger). Trial 4, social novelty testing: the second stranger (novel stranger) was placed in the second plastic cup-like cage in the opposite side-compartment. For each tested mouse, the side-compartments where the strangers were placed were alternated to avoid any side preferences. All trials were recorded by a video camera placed above the apparatus by using the Ethovision 11.5 software (Noldus, Netherlands) and the time spent in each chamber was manually analyzed. Trials where the mice have returned less than once time to the chamber are removed.
Splash:
The splash test was performed as previously described (Moretti et al; . Mice were sprayed in the dorsal coat with a 10% sucrose solution. The viscosity of this solution dirties the mice and initiates the grooming behavior. After being sprayed, mice were individually placed in a plexiglass cylinder (15 x 45cm; Form X.L., France) and their behaviors were recorded for 5 minutes. Self-care and motivational behaviors were manually analyzed using three parameters: the duration of grooming, the latency to start the first grooming, and the frequency of grooming events. A grooming event was defined as at least one episode of any category of grooming (paw licking, head wash, body groom, leg licking, tail/genital licking).
Seizure testing: For testing of seizure susceptibility, we used convulsant agent flurothyl (2,2,2-trifluoroethyl ether, Sigma) that is widely used to study the epilepsy in different animal models (Villeneuve et al., 2000; Velíšek et al., 2011) . The advantage of the flurothyl, as compared to other pro-convulsive agents is that it could be used to induce epilepsy-like activity in juvenile P0-P30 rats and mice (Villeneuve et al., 2000; Velíšková et al., 2017) .
Because the latencies of the effects of flurothyl depend on large number of parameters including atmospheric pressure, humidity, temperature, movements of the air in experimental chamber, animal weight and age (Velíšková et al., 2017) all experiments were performed using pairs of littermate males (P15 and P30) that were placed in transparent hermetic two- Thereafter all mice started moving and exploring the cage, although their moving activity was not scored.
Flurothyl was progressively injected into the cage using nano-pump (Harvard apparatus) and homogeneously distributed using mini-ventilator incorporated into the chamber. Behavioral responses were recorded using a video camera. The latency of tonic-clonic seizures was determined post-hoc as time of the first body convulsion in continuous series of tonic-clonic seizures.
Statistical analysis
Statistical analyses were conducted with OriginPro 9.0.0 which also indicated that assumptions of normality (Shapiro-Wilk test) and equal variance (Brown-Forsyth test) were met. A P<0.05 was considered significant for these and all subsequent tests. For data displaying normal distribution and equal variance one-way or two-way (as indicated)
ANOVA and the post hoc Tukey test were used for multiple comparisons between groups.
For data displaying non-normal distribution or unequal variance, Mann-Whitney U-test was used for comparison between 2 independent groups and Wilcoxon matched pairs test was employed to compare paired data. The Chi-square test was used to determine the significance of the difference between the frequencies of event occurrence.. Sample size for each group reported in electrophysiological experiments is at least 5 neurons from at least 3 independent experiments. For the boxplots, the box extends from the first (Q1) to third (Q3) quartiles. The line inside the box represents the median. The whiskers define the outermost data point that falls within upper inner and lower inner fence (Q1-1.5(IQR)) and (Q3-1.5(IQR)), respectively.
RESULTS
Characterization of KCC2 E/+ mice
To determine the in vivo significance of phosphorylation at the WNK/SPAK-kinase dependent KCC2 Thr 906 /Thr 1007 phosphorylation motif (Rinehart et al., 2009; Inoue et al., 2012; Friedel et al., 2015) , we generated mice harboring phospho-mimetic glutamic acid substitutions at these sites (T906E/T1007E) via homologous recombination (Fig. 1A) .
Homozygous KCC2 E/E mice died within the first 4-12 hours after birth from apparent respiratory distress, but heterozygous KCC2 E/+ mice were viable, fertile and survived through adulthood. Compared to KCC2 +/+ littermates, the KCC2 E/+ mice showed no difference in the time of eye opening or in weight gain from postnatal days (P) 0 to P15 (Fig. 1B and C) .
Immunoprecipitation of KCC2 from hippocampal lysates using antibodies that recognize the native phosphorylated, but not mutated (T906E and T1007E) forms of KCC2 (Los Heros et al., 2014) , showed a significant decrease in KCC2 E/+ mice as compared to KCC2 +/+ littermates (Fig. 1D,E and F, two way-Anova test, see Table S1 for details on statistic). The abundance of total KCC2 in hippocampal lysates from KCC2 +/+ mice increased progressively from P5 to P15 (Fig. 1D and G (Lu et al., 1999; Stein et al., 2004) . A similar developmental up-regulation of KCC2 abundance was observed in hippocampi from KCC2 E/+ mice (Fig. 1G) . No difference in total KCC2 abundance was seen between KCC2 +/+ and KCC2 E/+ mice at all studied time points ( Fig. 1D and G and KCC2 E/+ mice ( Fig. S1C and D, Table S1 ).
KCC2
E/+ CA3 pyramidal neurons exhibit a delay in the GABAergic developmental sequence.
Phospho-mimetic KCC2 T906E/T1007E mutation impairs Cl -extrusion capacity in vitro (Inoue et al., 2012; Friedel et al., 2015) . To test whether in vivo T906E/T1007E mutations alter neuronal Cl -homeostasis, we measured the driving force of GABA A channels (DF GABA )
in CA3 pyramidal neurons of acute hippocampal slices from KCC2 +/+ and KCC2 E/+ mice using non-invasive cell-attached single-GABA A channel recordings (Tyzio et al., 2003 (Tyzio et al., , 2014 .
In agreement with previous reports (Tyzio et al., 2006 (Tyzio et al., , 2014 , in slices prepared from P7-P9
+/+ mice, the DF GABA was positive in most recorded neurons (Fig. 2B , DF GABA =8.5±1.5 mV, (22 neurons, 7 mice [n=22,7])). Onwards from P12-14, DF GABA shifted towards less depolarizing and even hyperpolarizing values ( Fig. 2A and B mice, DF GABA remained strongly depolarized until P17-20 ( Fig. 2A and B There was, however, no significant difference in the resting membrane potential of KCC2 E/+ and KCC2 +/+ CA3 pyramidal neurons at P12-14 and P17-20 (Fig. 2C, Fig. S2 and Table S2 ).
These data show that the developmental hyperpolarizing GABA shift is delayed in the CA3 isoguvacine induced an increase of firing of CA3 pyramidal neurons in 83% of P6-9 slices (Fig. 2E, 17 slices, 4 mice [n=17, 4]). Starting from P14-17 no firing increase was observed in response to isoguvacine ( Fig. 2D and E) . Remarkably, in KCC2 E/+ mice, the isoguvacineinduced increase of firing persisted until P18 ( Fig. 2D and E, P=1E-5, Chi-square test).
Averaging the overall effect of isoguvacine on the firing of CA3 pyramidal neurons confirmed the delayed hyperpolarizing shift of GABA action in KCC2 E/+ mice (Fig. 2F , Table S2 ).
Altered glutamate/GABA balance in juvenile KCC2 E/+ CA3 pyramidal neurons.
A loss of equilibrium in glutamatergic and GABAergic synaptic drive has been observed in several NDDs associated with a delayed developmental GABA shift (Tyzio et al., 2014; Deidda et al., 2015; Banerjee et al., 2016) . We therefore performed whole cell recordings of CA3 pyramidal neurons in acute hippocampal slices at P15-20 and P30 to measure spontaneous GABA A R-mediated and glutamate mediated postsynaptic currents (sGABAPSCs and sGlut-PSCs) with a low Cl -pipette solution (Fig. 3A-D) . At P15-20, we found that the frequency of sGlut-PSCs, but not their amplitude, was increased in KCC2 E/+ CA3 pyramidal neurons compared to KCC2 +/+ littermates ( Fig. 3A-E) . In contrast, the frequencies of sGABA-PSCs were decreased in KCC2 E/+ CA3 pyramidal neurons, with no change in amplitude ( Fig. 3A-E) . At P30, whole cell recordings revealed no significant difference in the frequency or amplitude of sGlut-PSCs and sGABA-PSCs ( Fig. 3B-E Fig. 3D, E) . These data show that the E/I balance is impaired in CA3 neurons of P15-P20 KCC2 E/+ mice, coinciding with the depolarizing DF GABA .
Increased seizure susceptibility in juvenile KCC2 E/+ mice.
Genetic studies have shown an association between KCC2 dysfunction and different types of human epilepsy syndromes (Kahle et al., 2016b; Moore et al., 2017 
Altered vocalization and social interactions in KCC2 E/+ mice.
An increase in seizure susceptibility is a co-morbidity frequently associated with NDDs (Agrawal and Govender, 2011) . In addition, similar to described above changes in DF GABA and alterations in synaptic activity were reported in different animal models of NDD (Tyzio et al., 2014; Deidda et al., 2015; Banerjee et al., 2016) . We therefore assessed several neurobehavioral tests in KCC2 +/+ and KCC2 E/+ mice, including ultrasonic vocalization (USVs) (alteration of communication) (Scattoni et al., 2009) , open field (anxiety and hyperactivity) (Belzung and Griebel, 2001) , three-chamber test (sociability) (Silverman et al., 2010) , and grooming splash tests (depression) (Wang et al., 2018) .
USVs test were assessed in P2 to P12 mice. In KCC2 +/+ mice, the number of calls varied at different postnatal days and showed a typical ontogenetic profile (Wiaderkiewicz et al., 2013) (Fig. 5A) . KCC2 E/+ pups compared to KCC2 +/+ animals showed a statistically significant different ontogenetic profile ( Fig. 5A; P=0 .003, two-way Anova test). In P2 to P8 KCC2 E/+ mice, the number of ultrasonic calls was similar to KCC2 +/+ animals but at P10 and P12 the number of calls was higher ( Fig. 5A and B ; P=0.005 and P=0.003 for P10 and P12, respectively, post-hoc Tukey test).
The three-chamber test that was performed on P60 mice using widely explored paradigm (Peça et al., 2011) revealed difference in social behavior of KCC2 +/+ and KCC2 E/+ mice; while the wild type KCC2 +/+ mice spent ~35% more time to explore the compartment with stranger than the empty compartment (Fig. 5C, P=3 .7E-4, one-way Anova test), the KCC2 E/+ mice showed no interest to stranger and spent similar times in empty and stranger-containing compartments (Fig. 5D, P=0 .1, one-way Anova test). The three-chamber test allows determination of social novelty and exploration behavior. Both KCC2 +/+ and KCC2 E/+ mice spent more time to explore the novel stranger compartment than the familiar stranger compartment (Fig. S3A, P=0 (Fig. S4, Table S3 ). These data show that KCC2 T906E/T1007E impaired communication and sociability behavior.
Bumetanide restores altered glutamate/GABA balance and seizure susceptibility, but not vocalization and social interactions, in KCC2 E/+ mice.
Prenatal (Tyzio et al., 2014) or adult (Deidda et al., 2015; Dargaei et al., 2018) administration of the NKCC1 inhibitor bumetanide has been shown to alleviate symptoms in rat and mice animal models of NDDs, presumably due to rescuing of depolarizing action of GABA (Deidda et al., 2014) . We therefore examined whether bumetanide could restore neuronal network dysfunction and correct behavioral alterations in KCC2 E/+ mice.
To this aim, KCC2 E/+ mice received daily sub-cutaneous injection (0.2mg/kg) from P6 to P15, a period during which the hyperpolarizing shift of GABA responses occurs in KCC2 +/+ mice but failed in KCC2 E/+ mice. We found that the bumetanide treatment fully restored the E/I balance (Fig. 6A) In contrast, chronic bumetanide treatment from P6 to P15 did not normalize the social behavior deficits observed in KCC2 E/+ mice tested at P60. KCC2 E/+ mice treated with bumetanide spent as much time exploring the empty compartment and the compartment with strangers ( Fig. 6D , P= 0.13, n=7, one-way Anova test) as did untreated KCC2 E/+ mice (Fig.   5D ). As control experiments, KCC2 +/+ mice were treated with bumetanide from P6 to P15.
Like KCC2 +/+ mice, bumetanide-treated KCC2 +/+ mice spent more time to explore stranger compartment than empty compartment (Fig. 6D, P=0 .003, n=10, one-way Anova test).
DISCUSSION
By employing a multidisciplinary approach that includes biochemistry, electrophysiology, (Rubenstein and Merzenich, 2003; Cellot and Cherubini, 2014; Deidda et al., 2014) ). Furthermore, behavioral tests show phospho-mimetic KCC2 Thr 906 /Thr 1007 mutation lead to increased ultra-sonic vocalization during the two first postnatal weeks, higher susceptibility for seizure generation at P15, and impaired social interaction in P60 mice, three characteristic neurobehaviors associated with multiple NDDs (e.g., (Scattoni et al., 2009; Bey and Jiang, 2014; Pasciuto et al., 2015) ). Post-natal treatment with the NKCC1 blocker bumetanide restored E/I balance and normalized seizure thresholds but failed to restore the social interaction impairments. These data highlight the functional importance of KCC2's post-translational control in CNS development, and suggest impairment of this mechanism may contribute to the pathogenesis of certain symptoms associated with multiple different NDDs. consequently, reduced inhibitory strength of GABA (Friedel et al., 2015) . Interestingly, the developmental action of GABA in KCC2 E/+ mice was not abolished but delayed; at P30, the DF GABA and effect of isoguvacine were similar in KCC2 +/+ and KCC2 E/+ animals. This could be explained by compensation of the KCC2 T906E/T1007E allele by the developmental upregulation in KCC2 abundance and simultaneous Thr 906 /Thr 1007 de-phosphorylation in the wild type KCC2 allele. Together, these results indicate that post-translational modification of KCC2 is a determining factor in the post-natal emergence of functional GABAergic inhibition.
Delayed emergence of GABAergic inhibition in
KCC2 post-translational control of network function and seizure susceptibility
In addition to causing a reduction in the inhibitory strength of GABA, the T906E/T1007E
phospho-mimetic mutations of KCC2 caused a transient enhancement of network excitability and the susceptibility to generate seizures. All three parameters (DF GABA , the E/I ratio, and seizure susceptibility) are altered at P15, but not P30, indicating a correlation between the polarity of GABA, an increase in neuronal network activity, and the sensitivity to epileptogenic agents. Furthermore, chronic post-natal treatment with bumetanide rescued the E/I ratio and alleviated the sensitivity to epileptogenic agents. Interestingly, the same rescue of E/I ratio was observed after acute bumetanide application to hippocampal slices. Thus, the increase in network excitability and seizure susceptibility in KCC2 E/+ mice likely results from delayed depolarizing action of GABA and not from abnormal developmental sequences or reorganization of neuronal networks. Our findings also corroborate and extend recent work
showing that genetic mutation of Thr 906/1007 to alanine (Ala), the inverse of our phosphomimetic model that mimics constitutive dephosphorylation, enhances KCC2 activity and limits the onset and severity of seizures in homozygous mice (Moore et al., 2018) .
KCC2 post-translational control and NDDs
We have shown that KCC2 E/+ mice exhibit behavioral alterations, including an increase in the number of ultrasonic calls emitted by P10 and P12 isolated pups, and reduced social interactions in P60 mice, two key symptoms of ASDs. There was no difference in tests that evaluated anxiety, locomotion, and depression, although detailed investigations are needed to confirm these results. Previous work has implicated intrinsic KCC2 malfunction or dysregulation in different epilepsy subtypes (Palma et al., 2006; Huberfeld et al., 2007; Talos et al., 2012; Kahle et al., 2014; Puskarjov et al., 2014) , and multiple NDDs such as Schizophrenia, ASDs, Rett syndrome (Arion and Lewis, 2011; Tyzio et al., 2014; Merner et al., 2015; Sullivan et al., 2015; Banerjee et al., 2016; Tang et al., 2016) ; The present work is the first study demonstrating that the post-translational KCC2 control could be a risk factor in the NDDs etiology. Our findings extend several recent genetic studies that have identified mutation-linked modifications of the post-translational control of KCC2 in human neurological disorders (Kahle et al., 2014; Puskarjov et al., 2014; Stödberg et al., 2015) .
Interestingly, post-natal treatment with bumetanide in our mice model failed to rescue interaction social behavioral deficit. Thus, adult social interaction alteration does not depend on the post-natal developmental GABAergic sequence.
Link between electrophysiological alteration and neuro-behavioral modification
Impaired GABAergic neurotransmission and network activity dysregulation are hallmarks of NDD (Rubenstein and Merzenich, 2003; Cellot and Cherubini, 2014; Deidda et al., 2014) .
Impaired Cl-homeostasis and excitatory GABA activity have been reported in adult mice model of Rett syndrome (Banerjee et al., 2016) , Down syndrome (Deidda et al., 2015) and Huntington's disease (Dargaei et al., 2018) . In these models, bumetanide treatment in adults restored the hyperpolarizing action of GABA and alleviated the symptoms. In contrast, in our study, the alterations of social interaction are present while GABA has shifted toward hyperpolarizing direction. Thus, the KCC2 E/+ mice is a valuable model to study the pathophysiological importance of post-natal Cl-modification and neuronal network activity.
Previous studies have suggested dysregulation of the post-natal GABAergic sequence contributes to the pathogenesis of several neurological disorders by impairing neuronal network formation (Tyzio et al., 2006 (Tyzio et al., , 2014 Eftekhari et al., 2014; He et al., 2014) .
Consistent with this, hippocampal neurons of P0-P30 age Fragile X and Valproate mouse models of ASD exhibit increased post-natal Cl -and neuronal network activity He et al., 2014; Tyzio et al., 2014) . In these models, peri-natal treatment with bumetanide restored the GABAergic post-natal sequence (Tyzio et al., 2014) and adult behavior alterations . In our experiments, the P6-P15 post-natal treatment of KCC2 E/+ animals with bumetanide restored neuronal network activity at P15-P20, but failed to rescue compromised social behavior at P60. Taken together, these data indicate that the post-natal alteration of GABAergic transmission and network functioning is not implicated in social behavior modification and alteration of this phenomenon in KCC2 E/+ mice involves other KCC2-dependent mechanism. Contrary to KCC2 E/+ monogenic model, all cited above works were performed on multifactorial models involving long-lasting changes of large number of genes and signaling pathways (Bey and Jiang, 2014; De Rubeis et al., 2014; Ehrhart et al., 2016) as well as reported changes of neuronal Cl -homeostasis in brain slices from juvenile (P30, (Tyzio et al., 2014) ) or young adult (P60, (Deidda et al., 2015; Dargaei et al., 2018) ) animals.
Clinical relevance of KCC2 E/+ mice model.
Recent clinical studies revealed that heterozygous mutations in human KCC2 are associated with multiple neurological disorders featuring impaired Cl -homeostasis including several forms of epilepsy (Kahle et al., 2014; Puskarjov et al., 2014; Stödberg et al., 2015; Saitsu et al., 2016) , ASD, and schizophrenia (Merner et al., 2015) . How these mutations affect KCC2 activity and/or expression in humans and whether these mutations act in combination with other risk factors is presently unknown. In vitro experiments performed on cell cultures expressing KCC2 harboring human mutations suggest that at least some of these mutations impair critical post-translational modifications of KCC2 that alter its activity (Kahle et al., 2014; Stödberg et al., 2015) . Our study supports these genetic findings by showing that impaired regulation of KCC2 phosphorylation in even one allele can directly contribute to the formation of pathology relevant for multiple NDDs. These KCC2 T906E(A)/T1007E(A) transgenic animals thus represent valuable models to dissect the importance and effects of regulated KCC2 phosphorylation in vivo, and serve as genetic proof that drug development targeting these sites is a compelling strategy to powerfully modulate KCC2 activity. slices (first value) and number of animals (value after coma). *p<0.05; **p<0.01.
For more details on statistical tests see Table S2 . (n=10) and KCC2 E/+ (n=11) mice treated with bumetanide from P6 to P15 and studied at P60.
ns= non-significant, *P<0.05, one-way Anova test). 
